UTHR P/E ratio: current value, 10-year range and year-by-year history
Cash & Leverage
UTHR's p/e ratio is higher than 95% of the last 10 years.
P/E ratio History
UTHR P/E ratio by year
Yearly range of UTHR’s p/e ratio from 2016 to 2026. Over the full period it ranged from -47.1 to 23.4, averaging 9.3.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 16.7 | 19.1 | 22.1 | 19.5 |
| 2025 | 10.7 | 14.2 | 19.6 | 17.5 |
| 2024 | 10.6 | 13.9 | 18.0 | 14.3 |
| 2023 | 11.8 | 14.2 | 18.4 | 12.1 |
| 2022 | 12.1 | 16.8 | 21.3 | 18.9 |
| 2021 | 13.3 | 18.7 | 23.4 | 21.5 |
| 2020 | -47.1 | -1.0 | 14.2 | 13.1 |
| 2019 | -43.9 | -22.4 | 9.4 | -36.0 |
| 2018 | 7.0 | 10.1 | 16.3 | 8.1 |
| 2017 | 8.3 | 11.3 | 16.0 | 13.0 |
| 2016 | 7.5 | 8.8 | 9.8 | 9.7 |
Get notified when UTHR P/E ratio crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.
Price / Earnings Per ShareThe chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.
- Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
- A falling P/E trend may signal a business in structural decline, not a buying opportunity.
Is UTHR P/E ratio High or Low Right Now?
United Therapeutics Corporation's P/E ratio is currently 19.5, which is near historic high relative to its 10-year historical range. The 10-year median P/E ratio for UTHR is approximately 13.2. See all UTHR valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.